Table 2.

In-patient outcomes, adverse events, and 30-day follow-up in cohort of patients who underwent transfemoral transcatheter aortic valve implantation

Characteristics	All patients (n = 44)
Inpatient outcomes
All-cause death	0
Stroke	0
MI	0
Major bleeding	0
Complete heart block∗	4 (10)
Access closure complication†	2 (5)
Pericardial effusion‡	1 (2)
Hospital LOS, d (median, IQR)	1, 1–2
MG at discharge, mm Hg	9 ± 4
30-d outcomes
Cardiovascular mortality	0
Noncardiovascular mortality	1 (2)
Stroke	0
Rehospitalization rate	0
NYHA I–II at 30 d	44 (100)
MG at 30-d, mm Hg	12 ± 6

Values are n (%), or mean ± standard deviation, unless otherwise indicated.

IQR, interquartile range; LOS, length of stay; MG, mean gradient; MI, myocardial infarction; NYHA, New York Heart Association.

^∗Requiring permanent pacemaker implantation.

^†Failure of closure devices to achieve hemostasis at the arteriotomy site, leading to surgical vascular repair.

^‡Right ventricular pacing wire–related pericardial effusion (tamponade) necessitating pericardiocentesis.